The IHC staining patterns of ROS1 rearrangement cases and non-rearrangement cases. (ZIP 7.10 mb
Figure S1. Comparison of somatic mutation frequency between IBC and non-IBC in four subgroups. (a) T...
A Baseline NRG1 level in archival tumor samples by treatment group and indication. B Best percentage...
A) Molecular analysis of CBFA2T3-GLIS2 fusion gene. 1.M07e, 2.WSU-AML, 3.KASUMI1, 4.NOMO1, 5.OCI-AML...
Figure S10. Western blotting analysis in a cancer cell line with ROS1 fusion. Cell lysates were harv...
Figure S2. Summary of ALK, RET, or ROS1 fusion in 37 cancer cell lines. Plot of normalized values ca...
Figure S11. Western blotting analysis in five cancer cell lines without any fusion gene. Cell lysate...
Figure S6. Summary of ALK, RET, or ROS1 fusion in 4 tumor tissue specimens. Plot of normalized value...
Figure S5. RT-PCR analysis of ALK, RET, or ROS1 fusion in 4 tumor tissues. The mRNA expression of va...
Table S1. RT-PCR Targets within the Ion AmpliSeq™ Lung Fusion Research Panel. A list of all targets ...
Figure S1. RT-PCR analysis of ALK, RET, or ROS1 fusion in 37 cancer cell lines. The mRNA expression ...
Figure S9. Western blotting analysis in three cancer cell lines with or without RET fusion. Cell lys...
Figure S2. Box plot showing the distribution of TMB between the entire cohort of patients with SCLC ...
Figure S3. Kaplan-Meier analysis of (A) progression-free survival (PFS) and (B) overall survival (OS...
Figure S4. The comparison of commonly mutated genes in non-small cell lung cancer among three differ...
Table S1. Characteristics of the cell lines used in the study. Table S2. Primers and siRNA sequences...
Figure S1. Comparison of somatic mutation frequency between IBC and non-IBC in four subgroups. (a) T...
A Baseline NRG1 level in archival tumor samples by treatment group and indication. B Best percentage...
A) Molecular analysis of CBFA2T3-GLIS2 fusion gene. 1.M07e, 2.WSU-AML, 3.KASUMI1, 4.NOMO1, 5.OCI-AML...
Figure S10. Western blotting analysis in a cancer cell line with ROS1 fusion. Cell lysates were harv...
Figure S2. Summary of ALK, RET, or ROS1 fusion in 37 cancer cell lines. Plot of normalized values ca...
Figure S11. Western blotting analysis in five cancer cell lines without any fusion gene. Cell lysate...
Figure S6. Summary of ALK, RET, or ROS1 fusion in 4 tumor tissue specimens. Plot of normalized value...
Figure S5. RT-PCR analysis of ALK, RET, or ROS1 fusion in 4 tumor tissues. The mRNA expression of va...
Table S1. RT-PCR Targets within the Ion AmpliSeq™ Lung Fusion Research Panel. A list of all targets ...
Figure S1. RT-PCR analysis of ALK, RET, or ROS1 fusion in 37 cancer cell lines. The mRNA expression ...
Figure S9. Western blotting analysis in three cancer cell lines with or without RET fusion. Cell lys...
Figure S2. Box plot showing the distribution of TMB between the entire cohort of patients with SCLC ...
Figure S3. Kaplan-Meier analysis of (A) progression-free survival (PFS) and (B) overall survival (OS...
Figure S4. The comparison of commonly mutated genes in non-small cell lung cancer among three differ...
Table S1. Characteristics of the cell lines used in the study. Table S2. Primers and siRNA sequences...
Figure S1. Comparison of somatic mutation frequency between IBC and non-IBC in four subgroups. (a) T...
A Baseline NRG1 level in archival tumor samples by treatment group and indication. B Best percentage...
A) Molecular analysis of CBFA2T3-GLIS2 fusion gene. 1.M07e, 2.WSU-AML, 3.KASUMI1, 4.NOMO1, 5.OCI-AML...
DOI
Add to ORKG